Fortress Biotech, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Fortress Biotech, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Fortress Biotech, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $27.9M, a 25.6% increase year-over-year.
  • Fortress Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $32.7M, a 56.5% decline from 2022.
  • Fortress Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $75.3M, a 49.4% decline from 2021.
  • Fortress Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $149M, a 13.6% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $32.7M -$42.6M -56.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $75.3M -$73.7M -49.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $149M -$23.4M -13.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $172M +$25.7M +17.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $147M +$96.1M +190% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
2018 $50.6M -$99.7M -66.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $150M +$107M +250% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $42.9M -$18M -29.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 $60.9M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2013 $89.2M +$48.6M +120% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-14
2012 $40.5M +$17.4M +75.4% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-14
2011 $23.1M +$4.05M +21.3% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 $19M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.